KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Liabilities and Shareholders Equity (2016 - 2025)

Exact Sciences (EXAS) has disclosed Liabilities and Shareholders Equity for 16 consecutive years, with $5.9 billion as the latest value for Q4 2025.

  • Quarterly Liabilities and Shareholders Equity fell 1.14% to $5.9 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $23.3 billion through Dec 2025, down 9.55% year-over-year, with the annual reading at $5.9 billion for FY2025, 1.14% down from the prior year.
  • Liabilities and Shareholders Equity for Q4 2025 was $5.9 billion at Exact Sciences, down from $5.9 billion in the prior quarter.
  • The five-year high for Liabilities and Shareholders Equity was $6.7 billion in Q3 2024, with the low at $5.7 billion in Q1 2025.
  • Average Liabilities and Shareholders Equity over 5 years is $6.3 billion, with a median of $6.4 billion recorded in 2023.
  • The sharpest move saw Liabilities and Shareholders Equity surged 52.82% in 2021, then decreased 13.13% in 2025.
  • Over 5 years, Liabilities and Shareholders Equity stood at $6.7 billion in 2021, then fell by 6.85% to $6.2 billion in 2022, then rose by 3.93% to $6.5 billion in 2023, then dropped by 8.39% to $5.9 billion in 2024, then fell by 1.14% to $5.9 billion in 2025.
  • According to Business Quant data, Liabilities and Shareholders Equity over the past three periods came in at $5.9 billion, $5.9 billion, and $5.8 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.